NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 01:30PM ET
6.53
Dollar change
-0.47
Percentage change
-6.71
%
Index- P/E- EPS (ttm)-3.34 Insider Own0.00% Shs Outstand3.65M Perf Week-6.04%
Market Cap23.85M Forward P/E- EPS next Y- Insider Trans- Shs Float3.65M Perf Month-24.90%
Enterprise Value16.14M PEG- EPS next Q- Inst Own8.62% Short Float0.84% Perf Quarter7.76%
Income-12.19M P/S12.42 EPS this Y- Inst Trans-2.96% Short Ratio0.96 Perf Half Y-4.81%
Sales1.92M P/B3.34 EPS next Y- ROA-63.43% Short Interest0.03M Perf YTD-6.45%
Book/sh1.96 P/C3.09 EPS next 5Y- ROE-93.19% 52W High10.40 -37.21% Perf Year233.16%
Cash/sh2.11 P/FCF- EPS past 3/5Y32.81% 36.13% ROIC-170.59% 52W Low1.78 266.85% Perf 3Y43.52%
Dividend Est.- EV/EBITDA- Sales past 3/5Y14.73% -0.26% Gross Margin537.38% Volatility6.47% 11.82% Perf 5Y-82.63%
Dividend TTM- EV/Sales8.41 EPS Y/Y TTM-37.79% Oper. Margin-506.98% ATR (14)0.75 Perf 10Y-99.70%
Dividend Ex-Date- Quick Ratio8.90 Sales Y/Y TTM-83.56% Profit Margin-634.67% RSI (14)40.05 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio8.90 EPS Q/Q-319.12% SMA20-14.50% Beta1.46 Target Price10.00
Payout- Debt/Eq0.00 Sales Q/Q-100.00% SMA50-9.48% Rel Volume0.49 Prev Close7.00
Employees2 LT Debt/Eq0.00 EarningsMay 15 BMO SMA20011.13% Avg Volume32.02K Price6.53
IPOMar 21, 2014 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume15,696 Change-6.71%
Date Action Analyst Rating Change Price Target Change
Feb-09-18Initiated H.C. Wainwright Buy $5
May-15-25 08:05AM
Mar-21-25 08:05AM
Jan-22-25 08:00AM
Nov-13-24 09:00AM
Nov-08-24 10:26AM
09:05AM Loading…
Aug-13-24 09:05AM
May-29-24 08:45AM
May-15-24 09:35AM
May-10-24 01:53PM
08:05AM
Mar-28-24 10:54PM
09:05AM
Jan-08-24 09:00AM
Nov-09-23 09:05AM
Sep-19-23 09:05AM
09:05AM Loading…
Aug-23-23 09:05AM
Aug-10-23 09:05AM
Jul-11-23 09:05AM
Jun-15-23 09:20AM
May-24-23 09:05AM
May-12-23 09:05AM
May-02-23 09:05AM
Mar-30-23 09:05AM
Feb-06-23 09:10AM
Jan-25-23 09:05AM
Jan-23-23 09:05AM
Jan-04-23 09:05AM
Nov-10-22 09:05AM
Sep-26-22 09:00AM
Aug-08-22 09:05AM
09:00AM Loading…
Jul-12-22 09:00AM
May-12-22 09:05AM
Mar-29-22 09:05AM
Mar-21-22 08:05AM
Mar-17-22 04:05PM
Mar-01-22 09:31AM
09:00AM
Feb-24-22 04:05PM
Feb-02-22 11:28AM
Feb-01-22 09:00AM
Dec-17-21 04:30PM
Dec-15-21 08:00AM
Nov-17-21 03:01AM
Nov-10-21 04:15PM
Nov-09-21 09:00AM
Nov-04-21 03:01PM
Nov-02-21 02:20PM
Aug-14-21 03:57AM
Aug-10-21 09:10AM
04:38AM
Jul-30-21 03:00PM
Jul-27-21 10:00AM
May-11-21 04:35PM
Apr-15-21 09:15AM
Apr-12-21 05:41PM
09:00AM
Mar-23-21 09:05AM
Mar-04-21 09:15AM
Feb-16-21 01:30PM
Feb-11-21 12:24AM
Nov-12-20 09:00AM
Nov-09-20 01:39PM
Oct-21-20 09:00AM
Sep-30-20 08:30AM
Sep-29-20 08:30AM
Sep-22-20 08:30AM
Aug-07-20 09:00AM
Jul-08-20 08:30AM
Jun-26-20 09:00AM
May-27-20 09:00AM
May-14-20 09:00AM
Apr-29-20 10:02AM
Apr-16-20 05:25PM
08:30AM
Mar-26-20 09:00AM
Jan-31-20 07:20AM
Jan-30-20 08:00AM
Jan-16-20 12:05PM
Jan-06-20 08:58AM
Jan-03-20 09:55AM
Jan-02-20 08:51AM
Nov-04-19 09:15AM
Nov-01-19 09:00AM
Sep-18-19 09:30AM
Aug-19-19 09:25AM
Aug-05-19 09:00AM
Jun-07-19 10:25AM
Jun-06-19 06:42AM
May-16-19 09:10AM
May-15-19 09:00AM
Apr-15-19 09:00AM
Apr-08-19 04:29PM
Apr-03-19 09:30PM
Apr-01-19 05:33PM
02:34PM
09:00AM
Mar-14-19 09:45AM
Mar-12-19 12:22PM
Mar-08-19 01:00PM
Feb-19-19 09:00AM
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.